BioXcel Therapeutics Inc.

3.81
1.65 (76.39%)
At close: Mar 03, 2025, 3:59 PM
3.43
-9.97%
After-hours: Mar 03, 2025, 07:59 PM EST

BioXcel Therapeutics Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -7.68 -56.03 -80.45 -195.45 -117.76 -46.7 -590.64 -1.3K -4.42K
PEG Ratio -23.54 -1.08 -11.7 -2.17 -2.32 -0.14 -5.17 -5.19 n/a
PS Ratio 996.30 25.68K n/a n/a n/a n/a n/a n/a n/a
PB Ratio -24.33 125.41 38.70 77.54 141.58 23.14 -2.73K -8.52K n/a
P/FCF Ratio -8.87 -71.07 -103.86 -240.42 -135.27 -64.98 -1.22K -2.13K -10.01K
P/OCF Ratio -8.87 -71.14 -104.42 -241.57 -139.58 -66.62 -1.22K -2.13K -10.05K
OCF/S Ratio -112.32 -360.91 n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -1.79 1.23 0.01 0.01 0.04 n/a -0.38 n/a n/a
Quick Ratio 2.57 6.11 13.98 18.33 4.03 9.26 0.38 0.01 n/a
Current Ratio 2.65 6.17 13.98 18.33 4.03 9.26 0.38 0.01 n/a
Asset Turnover 0.02 0.00 n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -12.9 -19.44 -2.67K -3.05K n/a n/a -2.27K n/a n/a
Return on Equity (ROE) 3.17 -2.24 -0.48 -0.4 -1.2 -0.5 4.62 6.54 n/a
Return on Assets (ROA) -2.43 -0.83 -0.45 -0.37 -0.89 -0.44 -3.35 -302.86 n/a
Return on Capital (ROIC) -3.7 -0.92 -0.48 -0.4 -1.2 -0.51 4.62 6.54 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 8.70% 94.67% n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin -12.97K% -45.83K% n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin -12.97K% -44.2K% n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin -12.45K% -42.57K% n/a n/a n/a n/a n/a n/a n/a
FCF Margin -11.23K% -36.13K% n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin -11.99K% -41.97K% n/a n/a n/a n/a n/a n/a n/a